Literature DB >> 9573607

Antisense therapeutics.

S T Crooke1.   

Abstract

Mesh:

Substances:

Year:  1998        PMID: 9573607     DOI: 10.1080/02648725.1998.10647954

Source DB:  PubMed          Journal:  Biotechnol Genet Eng Rev        ISSN: 0264-8725


× No keyword cloud information.
  4 in total

Review 1.  Antisense technology: an overview and prospectus.

Authors:  Stanley T Crooke; Brenda F Baker; Rosanne M Crooke; Xue-Hai Liang
Journal:  Nat Rev Drug Discov       Date:  2021-03-24       Impact factor: 84.694

2.  Mapping of accessible sites for oligonucleotide hybridization on hepatitis delta virus ribozymes.

Authors:  J Wrzesinski; M Legiewicz; J Ciesiołka
Journal:  Nucleic Acids Res       Date:  2000-04-15       Impact factor: 16.971

3.  Enhanced activity of antisense phosphorothioate oligos against leishmania amastigotes: augmented uptake of oligo, ribonuclease H activation, and efficient target intervention under altered growth conditions.

Authors:  M Mishra; J M Porter-Kelley; P K Singh; J R Bennett; G Chaudhuri
Journal:  Biochem Pharmacol       Date:  2001-09-01       Impact factor: 5.858

4.  Toxicological and pharmacokinetic properties of chemically modified siRNAs targeting p53 RNA following intravenous administration.

Authors:  James D Thompson; Douglas J Kornbrust; Jeffrey W-D Foy; Elisabeth C R Solano; David J Schneider; Elena Feinstein; Bruce A Molitoris; Shai Erlich
Journal:  Nucleic Acid Ther       Date:  2012-08       Impact factor: 5.486

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.